Combination of Rapamycin, CI-1040, and 17-Aag Inhibits Metastatic Capacity of Prostate Cancer via Slug Inhibition

PLoS ONE - United States
doi 10.1371/journal.pone.0077400
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Combination of Quercetin and Hyperoside Inhibits Prostate Cancer Cell Growth and Metastasis via Regulation of microRNA-21

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2014English

Targeted Inhibition of Mammalian Target of Rapamycin Signaling Inhibits Tumorigenesis of Colorectal Cancer

Clinical Cancer Research
Cancer ResearchOncology
2009English

Rapamycin by Itself and Additively in Combination With Carboplatin Inhibits the Growth of Ovarian Cancer Cells

Gynecologic Oncology
GynecologyOncologyObstetrics
2009English

Systemic Inhibition of Mammalian Target of Rapamycin Inhibits Fear Memory Reconsolidation

Neurobiology of Learning and Memory
Cognitive PsychologyBehavioral NeuroscienceExperimentalCognitive Neuroscience
2008English

Prostate Cancer Predisposition Loci and Risk of Metastatic Disease and Prostate Cancer Recurrence

Clinical Cancer Research
Cancer ResearchOncology
2011English

Paeoniflorin Inhibits Cell Viability and Invasion of Liver Cancer Cells via Inhibition of Skp2

Oncology Letters
Cancer ResearchOncology
2020English

Clonal Origin and Spread of Metastatic Prostate Cancer

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2016English

MicroRNA-186 and Metastatic Prostate Cancer.

English

Predicting Bone Metastatic Potential of Prostate Cancer via Computational Modeling of TGF-Beta Signaling

2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy